Common Warrants issued January 13, 2022
Issued 2022
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: OTC
DilutionScan read 9 of Evofem Biosciences, Inc.'s SEC filings and found 17 warrant series, 7 convertibles and 1 completed offering on file for EVFM. The latest dilution event on file is an offering on Jul 8, 2026. Analysis updated Nov 1, 2026.
Raise routes on file: no active ATM, effective shelf, S-1 or equity line in the filings read · latest dilution event 118 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jul 8, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z